Search
for

    Research 10 of 97

    1. Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database Frontiers in Oncology · 2026
    2. Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer Journal of the American Academy of Dermatology · 2014 · 88 citations
    3. The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma Current Dermatology Reports · 2013 · 6 citations
    4. Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy Dermatology Review · 2016 · 4 citations
    5. Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution Cancers · 2024 · 3 citations
    6. Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database Dermatologic Therapy · 2025 · 1 citations
    7. Cemiplimab-Induced Alopecia Areata International Journal of Trichology · 2023
    8. ODP342 Panhypopituitarism Induced by CTLA-4 and PD-1/PD-L1 Inhibitor Immunotherapy Journal of the Endocrine Society · 2022
    9. Tombo em João Pessoa dá força a Memorial da Arquitetura Paraibana Projeto: revista mensal de arquitetura · 2008
    10. A bibliometric study of the top 100 most cited articles on melanoma: insights into research trends and characteristics Dermatology Reports · 2025
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →